Prerna Pathology Private Limited
Founded in 2002 and headquartered in Gujarat, India.
2002 | Ahmedabad, Gujarat (India) | Active
Prerna Pathology Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth -6.49%
- Profit Growth -33.51%
- Ebitda -2.21%
- Net Worth -52.60%
- Total Assets 0.70%
About Prerna Pathology
Prerna Pathology Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 December 2002 and has a history of 22 years and two months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhumica Patel, Jagdish Patel, and Kiran Chokhawala serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110GJ2002PTC041705
- Company No.
041705
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2002
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Healthcare
Who are the key members and board of directors at Prerna Pathology?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhumica Patel  | Director | 17-Dec-2002 | Current |
| Jagdish Patel | Director | 17-Dec-2002 | Current |
| Kiran Chokhawala | Director | 13-Aug-2018 | Current |
Financial Performance of Prerna Pathology.
Prerna Pathology Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 6.49% decrease. The company also saw a substantial fall in profitability, with a 33.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prerna Pathology?
In 2017, Prerna Pathology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prerna Pathology?
Unlock and access historical data on people associated with Prerna Pathology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prerna Pathology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prerna Pathology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.